Clinical Trial Update: A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating caspofungin (MK0991) in Japanese patients with invasive Candida or invasive Aspergillus infections has completed, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Candidiasis

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-08-26